本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Edgewise Therapeutics, Inc.

14.30
-0.5500-3.70%
成交量:48.54万
成交额:698.14万
市值:15.06亿
市盈率:-9.22
高:14.86
开:14.86
低:14.21
收:14.85
52周最高:38.12
52周最低:10.60
股本:1.05亿
流通股本:6,053.37万
量比:0.82
换手率:0.80%
股息:- -
股息率:- -
每股收益(TTM):-1.5508
每股收益(LYR):-1.4480
净资产收益率:-27.41%
总资产收益率:-19.06%
市净率:2.56
市盈率(LYR):-9.88

数据加载中...

2022/09/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/23

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/16

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/16

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/14

重要事件披露

8-K - Current report
2022/09/13

重要事件披露

8-K - Current report
2022/08/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/08/04

重要事件披露

8-K - Current report
2022/08/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/24

重要事件披露

8-K - Current report
2022/05/11

重要事件披露

8-K - Current report
2022/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/03

SEC问询函

CORRESP [Cover] - Correspondence
2022/02/24

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/24

重要事件披露

8-K - Current report
2022/02/24

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals